A Clinical Study of Borderline Malignant Tumors of the Ovary.
- Author:
Sang Hag LEE
1
;
Hyun Il CHOI
;
Byung Wook KIM
;
Geon Young LEE
;
Dong Soo CHA
;
Young Jin LEE
Author Information
1. Department of Obstetrics and Gynecology, Yonsei University, Wonju college of Medicine, Wonju, Korea.
- Publication Type:Original Article
- Keywords:
Ovarian tumor;
Borderline ovarian malignancy
- MeSH:
Age Distribution;
Aged;
Classification;
Drug Therapy;
Female;
Gangwon-do;
Gynecology;
Humans;
Hysterectomy;
Incidence;
Lost to Follow-Up;
Mucins;
Obstetrics;
Ovary*;
Parity;
Prognosis;
Retrospective Studies
- From:Korean Journal of Obstetrics and Gynecology
2001;44(11):1993-1999
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to review the clinical features, treatments and prognosis of the borderline malignant tumors of the ovary. METHODS: Thirty-two patients with borderline malignant tumors of the ovary were admitted, operated and confirmed with postoperative histopathological study at department of obstetrics and gynecology, Yonsei University Wonju Christian Hospital. The data were collected retrospectively and all charts were reviewed. RESULTS: The incidence of borderline malignant ovarian tumor was 19.2% (32/167). Age distribution revealed between 18 and 77 years old, the mean age was 43.1 years old. As for the parity distribution of borderline malignant tumor, nulliparity was most common (43.8%). The most common chief complaint was abdominal distension (34.4%). Histologic subtypes were mucinous in 19 cases (59.4%), serous in 13 cases (40.6%). According to FIGO classification, 28 cases (87.5%) were stage I, 1 case (3.1%) was stage II, 3 cases (9.4%) were stage III. Sixteen cases (50%) underwent conservative surgery (unilateral salpingooophorectomy or cystectomy). Sixteen cases (50%) were treated with total abdominal hysterectomy and bilateral salpingooophorectomy. Fifteen cases (46.9%) received adjuvant postoperative chemotherapy. Excluding 5 cases lost to follow up, patients were alive and were followed from 9 months to 100 months. (mean 36 months).
